PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Dazzle™ 594 anti-human CD73 (Ecto-5'-nucleotidase), 25 tests
PE/Dazzle™ 594 anti-human CD8, 100 tests
PE/Dazzle™ 594 anti-human CD8, 25 tests
PE/Dazzle™ 594 anti-human CD80, 100 tests
PE/Dazzle™ 594 anti-human CD80, 25 tests
PE/Dazzle™ 594 anti-human CD83, 100 tests
PE/Dazzle™ 594 anti-human CD83, 25 tests
PE/Dazzle™ 594 anti-human CD86, 100 tests
PE/Dazzle™ 594 anti-human CD86, 25 tests
PE/Dazzle™ 594 anti-human CD8a, 100 tests
PE/Dazzle™ 594 anti-human CD8a, 25 tests
PE/Dazzle™ 594 anti-human CD90 (Thy1), 100 tests
PE/Dazzle™ 594 anti-human CD90 (Thy1), 25 tests
PE/Dazzle™ 594 anti-human CD95 (Fas), 100 tests